BCL2 and diffuse large B-cell lymphoma: The NCT02706405 study enrolled 15 patients, in which 12 were DLBCL, 2 were high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements, and 1 was PMBL.